SCHEMBL22425697

SCHEMBL22425697

NCC(=O)Oc1ccc(CO)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.44
PPARA Q07869 2/20 0.44
LTA4H P09960 1/20 0.44
KMT2A Q03164 7/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
THRB P10828 2/20 0.40
CA12 O43570 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CA5B Q9Y2D0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18613655 0.83 KMT2A (0.61) PPARGPPARALTA4HKMT2AALDH1A1
SCHEMBL18274704 0.82 TAAR1 (0.52) KMT2AALDH1A1THRB
SCHEMBL14416710 0.82 RAB9A (0.50) PPARGPPARAKMT2AALDH1A1LMNA
SCHEMBL23799441 0.80 KMT2A (0.51) PPARGPPARALTA4HKMT2AALDH1A1
SCHEMBL16281795 0.80 PPARG (0.44) PPARGPPARALTA4HKMT2AALDH1A1
SCHEMBL170186 0.80 KMT2A (0.61) PPARGPPARALTA4HKMT2AALDH1A1
SCHEMBL11351213 0.79 KMT2A (0.40) KMT2AALDH1A1LMNAMAPTHTT
SCHEMBL343571 0.79 THRB (0.60) PPARGPPARAKMT2AALDH1A1LMNA
SCHEMBL11151702 0.79 KMT2A (0.45) KMT2AALDH1A1LMNAMAPTHTT
SCHEMBL13650268 0.79 MEN1 (0.48) PPARGPPARALTA4HKMT2ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11857635-B2 Linker compound, polyethylene glycol-linker conjugate and derivative thereof and polyethylene glycol-linker-drug conjugate JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) 2024-01-02 US disclosed
US-20200289655-A1 Linker Compound, Polyethylene Glycol-Linker Conjugate and Derivative Thereof and Polyethylene Glycol-Linker-Drug Conjugate JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) 2020-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200289655-A1 Linker Compound, Polyethylene Glycol-Linker Conjugate and Derivative Thereof and Polyethylene Glycol-Linker-Drug Conjugate DCLRE1A, LANCL2, SI PPARG 2783/4885PPARA 2376/4885LTA4H 1075/4885
US-11857635-B2 Linker compound, polyethylene glycol-linker conjugate and derivative thereof and polyethylene glycol-linker-drug conjugate DCLRE1A, LANCL2, SI PPARG 2783/4885PPARA 2376/4885LTA4H 1075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.